NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Unlearn

Unlearn

Private
San Francisco, CaliforniaAI, Data & Cloud Infrastructurehttps://www.unlearn.ai/

Last Round

Series C

Feb 8, 2024

Est. Valuation

$265M

Total Funding Raised

$142.05M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Unlearn is a healthcare technology company that develops an AI platform creating digital twins of clinical trial participants to enable smaller, faster, and more successful studies.

Sector

AI, Data & Cloud Infrastructure

Verticals

Clinical Trials, Medical AI, Synthetic Data, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital twinsynthetic control armgenerative AIclinical trial optimizationAI for drug developmentTwinRCTsin silico trialsvirtual control armhealth outcome forecastingsynthetic patient datatrial simulationDigital Twin GeneratorsDTGsEMA qualification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Unlearn Comparables

Compare Unlearn with similar companies based on industry and business-model similarity.

Unlearn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QuantHealth
84%
Nova In Silico
74%
InSilicoTrials Technologies
73%

Unlearn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CFeb 8, 2024
Early FundingMar 22, 2023
Series BApr 19, 2022
Series A ExtensionNov 5, 2020
Series AApr 20, 2020
Seed
Jul 12, 2019

Key People

Founding team and executive leadership

Steven Herne

Chief Executive Officer, Chief Commercial Officer

Executive Team

Jack J. McGovern

Chief Financial Officer

Executive Team

Unlearn Investors

Notable investors and investment history

Unlearn investors
InvestorRounds
DCVC BioSeries A, Series C, Series B, Seed
Founders FundSeries A, Series B
Global VenturesSeries B
Necessary VenturesSeries C
EPIC VenturesSeries A, Series C, Series A Extension
Mubadala CapitalSeed, Series A, Series C, Series B
Wittington VenturesSeries C, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 13, 2026

    Announced the release of AD DTG 4.2, an Alzheimer's disease Digital Twin Generator update.

  • Feb 12, 2026

    Partnering with VectorY Therapeutics for PIONEER-ALS study using digital twins.

Unlearn Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Unlearn Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Unlearn's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range76
Year Founded2017
Last FundingFeb 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.